Latest News

Hawaiian Holdings to Pay Quarterly Cash Dividend Starting Next Month

Hawaiian Holdings to Pay Quarterly Cash Dividend Starting Next Month

October 16, 2017 at 2:57 pm 0 comments

Hawaiian Holdings (HA), parent company of Hawaiian Airlines, said pre-market Thursday it will start to pay a quarterly cash dividend. The company said it will pay a $0.12 a share dividend, effective Nov. 30, to all shareholders of record as of Nov. 17. The dividend will be in addition to the $100 million share repurchase program announced in April. AsRead More

Hourly Earnings Surge as Payrolls Drop 33,000 vs +100,000 Expected

Hourly Earnings Surge as Payrolls Drop 33,000 vs +100,000 Expected

October 10, 2017 at 9:06 pm 0 comments

U.S. nonfarm payrolls fell 33,000 in September versus the 100,000 increase expected, with August revised to 169,000 from 156,000 previously but July lowered to 138,000 from 189,000. That left the 3-month average at 91,000. The unemployment rate dropped to 4.2% from 4.4% (consensus: 4.4%). Hourly earnings surged 0.5% versus the 0.3% expected, from August’s 0.2% gain (revised higher from 0.1%).Read More

Financial Shares Mainly Higher Pre-Market

Financial Shares Mainly Higher Pre-Market

October 10, 2017 at 9:05 pm 0 comments

Financial shares were higher ahead of opening bell Friday following the report that U.S. employment dropped 33,000 in September due to hurricanes Harvey and Irma. Forecasts had called for a 75,000 increase in nonfarm jobs, but estimates may not be comparable because of the uncertainty surrounding the impact of the storms. The unemployment rate, which was not affected by theRead More

Paratek Pharma Shares Rise 3% Pre-Bell as Study Shows ‘Potent’ Activity of Omadacycline vs Pathogens

Paratek Pharma Shares Rise 3% Pre-Bell as Study Shows ‘Potent’ Activity of Omadacycline vs Pathogens

October 10, 2017 at 9:04 pm 0 comments

Paratek Pharmaceuticals (PRTK) shares gained more than 3% in pre-market trade Friday after the company said a study showed that its once-daily, oral and IV, broad-spectrum investigational antibiotic, omadacycline is active against the clinically important typical and atypical community-acquired bacterial pneumonia pathogens. The data show in vitro antibacterial activity and clinical efficacy against gram-positive and gram-negative bacterial isolates, Paratek said.Read More

RBC Raises Costco PT to $190 on Q4 EPS Beat

RBC Raises Costco PT to $190 on Q4 EPS Beat

October 10, 2017 at 9:02 pm 0 comments

Costco Wholesale (COST) has had its price target raised by analysts at RBC to $190 from $184 on better-than-expected Q4 results. The firm maintained its outperform rating on the stock. Shares of Costco are down 3% in pre-market trading. In a note to clients, RBC said Costco’s sales and traffic remain “solid and consistent,” and cited traffic growth of “aRead More

Is Delta International Oil & Gas Inc. (OTCPK:DLTZ) Undervalued?

September 15, 2017 at 8:05 am 0 comments

Delta International Oil & Gas Inc. (OTCPK:DLTZ) has an ERP5 rank of 15476. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies.  It looks at the stock’s Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The lower the rank, the more undervalued a company is considered to be.   The Q.i. ValueRead More

Medicines Co. Price Target Boosted by Chardan to $85 From $80, Buy Rating Maintained

Medicines Co. Price Target Boosted by Chardan to $85 From $80, Buy Rating Maintained

August 30, 2017 at 2:10 pm 0 comments

Medicines Co. (MDCO) received a price-target boost Tuesday from Chardan Capital Markets following the biopharmaceutical company’s Monday release with partner Alnylam Pharmaceuticals (ALNY) of an encouraging update on their phase 2 trial of inclisiran in hypercholesterolemia. The new price target from Chardan is $85 per share, up from $80 and well above the stock’s Monday closing price of $37.72. ChardanRead More